US: FDA backs Pfizer COVID-19 boosters for seniors, high-risk

​​The FDA authorized booster doses for Americans who are 65 and older, younger adults with underlying health conditions and those in jobs that put them at high risk for COVID-19. The ruling represents a drastically scaled back version of the Biden administration's sweeping plan to give third doses to nearly all American adults.

from International-News-Economic Times https://ift.tt/2XREg19
via IFTTT
SHARE
    Blogger Comment
    Facebook Comment

0 comments:

Post a Comment